GlassScriptPhysician profile
James Earl Koon
NPI 1609983345
$1,141.20
in general payments reported to CMS, 2019-2025
9 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $226 · 2023: $92.51 · 2024: $496 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $745.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $256.47 | 2023-2025 | Grafix Pl, Stravix Pl |
| Wright Medical Technology, INC. | $209.90 | 2019-2020 | |
| Teleflex LLC | $164.14 | 2024 | Urolift |
| Nevro Corp. | $135.00 | 2024 | Senza |
| Intuitive Surgical, INC. | $119.36 | 2025 | |
| Boston Scientific Corporation | $93.45 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $73.39 | 2019 | |
| Horizon Therapeutics Plc | $70.20 | 2023 | Krystexxa |
| Cumberland Pharmaceuticals, INC. | $19.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Koon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.